Literature DB >> 14530500

Genetics and the management of women at high risk for breast cancer.

Betty A Mincey1.   

Abstract

It is estimated that 5%-10% of all breast cancers in women are associated with hereditary susceptibility due to mutations in autosomal dominant genes, such as BRCA1 and BRCA2, p53, pTEN, and STK11/LKB1. Another 15%-20% of female breast cancers occur in women with a family history but without an apparent autosomal dominant inheritance pattern, and are probably due to other genetic factors with environmental influence. Approximately 7%-10% of ovarian cancers occur in women with hereditary susceptibility, primarily secondary to mutations in BRCA1 and BRCA2, with smaller contributions from mutations in mismatch repair genes associated with the hereditary nonpolyposis colorectal cancer and other, as yet undiscovered, genes.

Entities:  

Mesh:

Year:  2003        PMID: 14530500     DOI: 10.1634/theoncologist.8-5-466

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  5 in total

1.  Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.

Authors:  Kelly-Anne Phillips; Phyllis N Butow; Ailsa E Stewart; Jiun-Horng Chang; Prue C Weideman; Melanie A Price; Sue Anne McLachlan; Geoffrey J Lindeman; Michael J McKay; Michael L Friedlander; John L Hopper
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells.

Authors:  Vikas Sehdev; James C K Lai; Alok Bhushan
Journal:  J Oncol       Date:  2010-02-11       Impact factor: 4.375

3.  An Example from the Rural Areas of Turkey: Women Breast Cancer Risk Levels and Application and Knowledge Regarding Early Diagnosis-Scan of Breast Cancer.

Authors:  Rukiye Türk; Kafiye Eroğlu; Füsun Terzioğlu; Lale Taşkın
Journal:  J Breast Health       Date:  2017-04-01

4.  Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort.

Authors:  Mohammed S Orloff; Li Zhang; Gurkan Bebek; Charis Eng
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

5.  Assessing Heavy Metal and PCB Exposure from Tap Water by Measuring Levels in Plasma from Sporadic Breast Cancer Patients, a Pilot Study.

Authors:  Anne Marie Zimeri; Sara Wagner Robb; Sayed M Hassan; Rupali R Hire; Melissa B Davis
Journal:  Int J Environ Res Public Health       Date:  2015-12-09       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.